Request for Covid-19 Impact Assessment of this Report

Materials and Chemicals

United States Voriconazole Market Report 2016

  • QYR778425
  • 109 Pages
  • November 2016
  • Materials and Chemicals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Voriconazole

Revenue, means the sales value of Voriconazole

This report studies sales (consumption) of Voriconazole in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Pfizer

Teva

GeneTech Pharm

Novartis

Mylan

Squibb

Sandoz

Daiichi Sankyo

GSK

Cilag AG

Macherey-Nagel GmbH

Abbott

Takeda

Sichuan Beauty Sport Huakang Pharmaceutical

Jincheng HEALTH Pharmaceutical

Ebang Pharmaceutical

Aditya Pharma

Taj Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Injection

Freeze-dried powder

Type III

Split by applications, this report focuses on sales, market share and growth rate of Voriconazole in each application, can be divided into

Hospital use

Clinic

Others

Table of Contents

United States Voriconazole Market Report 2016

1 Voriconazole Overview

1.1 Product Overview and Scope of Voriconazole

1.2 Classification of Voriconazole

1.2.1 Injection

1.2.2 Freeze-dried powder

1.2.3 Type III

1.3 Application of Voriconazole

1.3.1 Hospital use

1.3.2 Clinic

1.3.3 Others

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Voriconazole (2011-2021)

1.4.1 United States Voriconazole Sales and Growth Rate (2011-2021)

1.4.2 United States Voriconazole Revenue and Growth Rate (2011-2021)

2 United States Voriconazole Competition by Manufacturers

2.1 United States Voriconazole Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Voriconazole Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Voriconazole Average Price by Manufactures (2015 and 2016)

2.4 Voriconazole Market Competitive Situation and Trends

2.4.1 Voriconazole Market Concentration Rate

2.4.2 Voriconazole Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Voriconazole Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Voriconazole Sales and Market Share by Type (2011-2016)

3.2 United States Voriconazole Revenue and Market Share by Type (2011-2016)

3.3 United States Voriconazole Price by Type (2011-2016)

3.4 United States Voriconazole Sales Growth Rate by Type (2011-2016)

4 United States Voriconazole Sales (Volume) by Application (2011-2016)

4.1 United States Voriconazole Sales and Market Share by Application (2011-2016)

4.2 United States Voriconazole Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Voriconazole Manufacturers Profiles/Analysis

5.1 Pfizer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Voriconazole Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Teva

5.2.2 Voriconazole Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Teva Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 GeneTech Pharm

5.3.2 Voriconazole Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 GeneTech Pharm Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Novartis

5.4.2 Voriconazole Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Novartis Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Mylan

5.5.2 Voriconazole Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Mylan Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Squibb

5.6.2 Voriconazole Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Squibb Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Sandoz

5.7.2 Voriconazole Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Sandoz Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Daiichi Sankyo

5.8.2 Voriconazole Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Daiichi Sankyo Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 GSK

5.9.2 Voriconazole Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 GSK Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Cilag AG

5.10.2 Voriconazole Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Cilag AG Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Macherey-Nagel GmbH

5.12 Abbott

5.13 Takeda

5.14 Sichuan Beauty Sport Huakang Pharmaceutical

5.15 Jincheng HEALTH Pharmaceutical

5.16 Ebang Pharmaceutical

5.17 Aditya Pharma

5.18 Taj Pharmaceuticals

6 Voriconazole Manufacturing Cost Analysis

6.1 Voriconazole Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Voriconazole

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Voriconazole Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Voriconazole Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Voriconazole Market Forecast (2016-2021)

10.1 United States Voriconazole Sales, Revenue Forecast (2016-2021)

10.2 United States Voriconazole Sales Forecast by Type (2016-2021)

10.3 United States Voriconazole Sales Forecast by Application (2016-2021)

10.4 Voriconazole Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Voriconazole

Table Classification of Voriconazole

Figure United States Sales Market Share of Voriconazole by Type in 2015

Figure Injection Picture

Figure Freeze-dried powder Picture

Table Application of Voriconazole

Figure United States Sales Market Share of Voriconazole by Application in 2015

Figure Hospital use Examples

Figure Clinic Examples

Figure Others Examples

Figure United States Voriconazole Sales and Growth Rate (2011-2021)

Figure United States Voriconazole Revenue and Growth Rate (2011-2021)

Table United States Voriconazole Sales of Key Manufacturers (2015 and 2016)

Table United States Voriconazole Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Voriconazole Sales Share by Manufacturers

Figure 2016 Voriconazole Sales Share by Manufacturers

Table United States Voriconazole Revenue by Manufacturers (2015 and 2016)

Table United States Voriconazole Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Voriconazole Revenue Share by Manufacturers

Table 2016 United States Voriconazole Revenue Share by Manufacturers

Table United States Market Voriconazole Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Voriconazole Average Price of Key Manufacturers in 2015

Figure Voriconazole Market Share of Top 3 Manufacturers

Figure Voriconazole Market Share of Top 5 Manufacturers

Table United States Voriconazole Sales by Type (2011-2016)

Table United States Voriconazole Sales Share by Type (2011-2016)

Figure United States Voriconazole Sales Market Share by Type in 2015

Table United States Voriconazole Revenue and Market Share by Type (2011-2016)

Table United States Voriconazole Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Voriconazole by Type (2011-2016)

Table United States Voriconazole Price by Type (2011-2016)

Figure United States Voriconazole Sales Growth Rate by Type (2011-2016)

Table United States Voriconazole Sales by Application (2011-2016)

Table United States Voriconazole Sales Market Share by Application (2011-2016)

Figure United States Voriconazole Sales Market Share by Application in 2015

Table United States Voriconazole Sales Growth Rate by Application (2011-2016)

Figure United States Voriconazole Sales Growth Rate by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Voriconazole Sales Market Share (2011-2016)

Table Teva Basic Information List

Table Teva Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Voriconazole Sales Market Share (2011-2016)

Table GeneTech Pharm Basic Information List

Table GeneTech Pharm Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table GeneTech Pharm Voriconazole Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Voriconazole Sales Market Share (2011-2016)

Table Mylan Basic Information List

Table Mylan Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mylan Voriconazole Sales Market Share (2011-2016)

Table Squibb Basic Information List

Table Squibb Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Squibb Voriconazole Sales Market Share (2011-2016)

Table Sandoz Basic Information List

Table Sandoz Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sandoz Voriconazole Sales Market Share (2011-2016)

Table Daiichi Sankyo Basic Information List

Table Daiichi Sankyo Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daiichi Sankyo Voriconazole Sales Market Share (2011-2016)

Table GSK Basic Information List

Table GSK Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table GSK Voriconazole Sales Market Share (2011-2016)

Table Cilag AG Basic Information List

Table Cilag AG Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cilag AG Voriconazole Sales Market Share (2011-2016)

Table Macherey-Nagel GmbH Basic Information List

Table Macherey-Nagel GmbH Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Macherey-Nagel GmbH Voriconazole Sales Market Share (2011-2016)

Table Abbott Basic Information List

Table Abbott Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Voriconazole Sales Market Share (2011-2016)

Table Takeda Basic Information List

Table Takeda Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Voriconazole Sales Market Share (2011-2016)

Table Sichuan Beauty Sport Huakang Pharmaceutical Basic Information List

Table Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales Market Share (2011-2016)

Table Jincheng HEALTH Pharmaceutical Basic Information List

Table Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Jincheng HEALTH Pharmaceutical Voriconazole Sales Market Share (2011-2016)

Table Ebang Pharmaceutical Basic Information List

Table Ebang Pharmaceutical Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ebang Pharmaceutical Voriconazole Sales Market Share (2011-2016)

Table Aditya Pharma Basic Information List

Table Aditya Pharma Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Aditya Pharma Voriconazole Sales Market Share (2011-2016)

Table Taj Pharmaceuticals Basic Information List

Table Taj Pharmaceuticals Voriconazole Sales, Revenue, Price and Gross Margin (2011-2016)

Table Taj Pharmaceuticals Voriconazole Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Voriconazole

Figure Manufacturing Process Analysis of Voriconazole

Figure Voriconazole Industrial Chain Analysis

Table Raw Materials Sources of Voriconazole Major Manufacturers in 2015

Table Major Buyers of Voriconazole

Table Distributors/Traders List

Figure United States Voriconazole Production and Growth Rate Forecast (2016-2021)

Figure United States Voriconazole Revenue and Growth Rate Forecast (2016-2021)

Table United States Voriconazole Production Forecast by Type (2016-2021)

Table United States Voriconazole Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Global Photonic Crystals Market (Construction Strategies, Geography , Applications) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.

  • Publish Date: February 8, 2017
  • $5370
Molded Plastics Market by Product (Polyvinyl Chloride, Polypropylene, Polystyrene, Low Density Polyethylene, High Density Polyethylene, Polyethylene Terephthalate, and Engineering Plastics), Technology (Injection Molding, Blow Molding, Extrusion, and Others), and Application (Building & Construction, Electrical & Electronics, Automotive and Packaging) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...

  • Publish Date: July 4, 2017
  • $5370